Tizanidine Tablets recall
FDA recall D-0223-2024 · initiated Jan 2, 2024
Dr. Reddy's Laboratories, Inc. recalled Tizanidine Tablets in Jan 2024 — an FDA Class II recall (D-0223-2024) because Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 38,952 bottles
Details
- Product
- Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
- Recalling company
- Dr. Reddy's Laboratories Limited
- Classification
- Class II
- Status
- Completed
- Type
- Voluntary: Firm initiated
- Distribution
- USA Nationwide
- Initiated
- Jan 2, 2024
- FDA report date
- Jan 17, 2024
Frequently asked
- Was Tizanidine Tablets recalled?
- Dr. Reddy's Laboratories, Inc. recalled Tizanidine Tablets in Jan 2024 — an FDA Class II recall (D-0223-2024) because Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Tizanidine Tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0223-2024 was: Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
- Is a recalled Tizanidine Tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Tizanidine Tablets are affected?
- Distributed: USA Nationwide. The recall covers these lots — Lot #: T2304007, Exp 7/31/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0223-2024.